Literature DB >> 2941402

Pharmacokinetics of oral ciprofloxacin, 100 mg single dose, in volunteers and elderly patients.

A P Ball, C Fox, M E Ball, I R Brown, J V Willis.   

Abstract

The pharmacokinetics of ciprofloxacin following a single 100 mg oral dose were evaluated in elderly patients (mean age 74 years), laboratory staff (30-40 years) and students (less than 20 years). There were no significant differences in serum Tmax (1.2-1.3 h) or in overall serum elimination half-life (3.7-4.0 h) but Cmax in elderly patients was more than double that in young volunteers (P less than 0.005). The serum AUC value was greater both in fasting students (1.4 mg/h/l) compared with the same subjects after food (1.09: P less than 0.01) and, after food, in elderly patients (1.95) compared with students (0.81: P less than 0.005). Urinary recoveries were greater in fasting subjects and in all categories of volunteers compared with elderly patients. However, in the elderly, urinary ciprofloxacin concentrations (0-6 h mean 66 mg/l: range 17.4-200 mg/l) were more than adequate for the eradication of urinary pathogens.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2941402     DOI: 10.1093/jac/17.5.629

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  23 in total

1.  Comparison of three dosage regimens of ciprofloxacin in urinary tract infections.

Authors:  V Prát; M Horcicková; K Matousovic; M Hatala
Journal:  Int Urol Nephrol       Date:  1990       Impact factor: 2.370

Review 2.  Pharmacokinetics of antimicrobial agents in organ function impairment. A review.

Authors:  R Janknegt
Journal:  Pharm Weekbl Sci       Date:  1990-08-24

3.  Comparative study of pharmacokinetics of two new fluoroquinolones, balofloxacin and grepafloxacin, in elderly subjects.

Authors:  O Kozawa; T Uematsu; H Matsuno; M Niwa; S Nagashima; M Kanamaru
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

4.  Pharmacokinetics of ciprofloxacin in the elderly: increased oral bioavailability and reduced renal clearance.

Authors:  B Ljungberg; I Nilsson-Ehle
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-06       Impact factor: 3.267

5.  Effects of antacids and dialysate dwell times on multiple-dose pharmacokinetics of oral ciprofloxacin in patients on continuous ambulatory peritoneal dialysis.

Authors:  T A Golper; A I Hartstein; V H Morthland; J M Christensen
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

Review 6.  Ciprofloxacin. A review of its pharmacological profile and therapeutic use in the elderly.

Authors:  L R Wiseman; J A Balfour
Journal:  Drugs Aging       Date:  1994-02       Impact factor: 3.923

7.  Concentration of ciprofloxacin in bone tissue after single parenteral administration to patients older than 70 years.

Authors:  H Wacha; D Wagner; V Schäfer; H Knothe
Journal:  Infection       Date:  1990 May-Jun       Impact factor: 3.553

8.  Pharmacokinetics and bioavailability of intravenous-to-oral enoxacin in elderly patients with complicated urinary tract infections.

Authors:  C R Marchbanks; D J Mikolich; K H Mayer; S H Zinner; M N Dudley
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

Review 9.  Clinical pharmacokinetics of ciprofloxacin.

Authors:  K Vance-Bryan; D R Guay; J C Rotschafer
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

Review 10.  Quinolone disposition in the elderly. Practical implications.

Authors:  I Nilsson-Ehle; B Ljungberg
Journal:  Drugs Aging       Date:  1991 Jul-Aug       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.